Market Positioning As a software development company with a focus on innovative solutions and recent efforts to transfer its listings to NYSE American, there is potential to offer advanced trading, compliance, and data analytics tools tailored for listed companies in transition or facing regulatory compliance challenges.

Partnership Opportunities The company's involvement with the biotech sector through its business combination with Addimmune indicates openness to collaborations in health tech, genomics, and clinical data management, presenting avenues for software solutions that enhance research, development, and regulatory reporting.

Technology Enhancement Utilizing cloud-based infrastructure like Google Cloud and various web technologies suggests a readiness for scalable, cloud-native solutions; sales opportunities exist in AI, data security, and platform integration services to optimize their digital operations.

Funding & Growth With recent funding levels and a revenue range of 10M to 25M, there is a demand for financial management, investor relations, and analytics tools to support their growth, reporting accuracy, and investor engagement strategies.

Regulatory & Compliance The company's ongoing compliance issues and regulatory notices from NYSE highlight a need for compliance solutions, automated reporting, and governance management tools to streamline their regulatory interactions and ensure timely filings.